Tysabri may be possible for more MS patients with new test

A board to discuss the newly-released drug Tysabri, (formerly known as Antegren) as a treatment for Multiple Sclerosis

Tysabri may be possible for more MS patients with new test

Postby MSUK » Tue Oct 08, 2013 3:55 am

A blood test for L-selectin expression on circulating immune cells may identify multiple sclerosis patients who could safely receive natalizumab (Tysabri) despite past exposure to the JC virus, a small study presented here suggested.

All MS patients taking natalizumab who developed the rare but life-threatening brain inflammation called progressive multifocal leukoencephalopathy (PML) in the study had very low levels of L-selectin expression, which was not seen in other patients who did not develop PML or in controls, said Heinz Wiendl, MD, of the University of Muenster in Germany...... Read More - http://www.ms-uk.org/tysabri
MS-UK - http://www.ms-uk.org/
User avatar
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 3:00 pm


Re: Tysabri may be possible for more MS patients with new te

Postby HarryZ » Thu Oct 10, 2013 11:11 am

Wiendl reported relationships with Bayer Schering, Biogen Idec, Merck Serono, Novartis, Sanofi, Teva, and Novo Nordisk.

All the MS drug manufacturers! Guess whose benefit he is working for?!

In this case, Biogen looks like they are doing everything they can to increase that market share for Ty$abri.

User avatar
Family Elder
Posts: 2570
Joined: Tue May 25, 2004 3:00 pm
Location: London, ON, Canada

Return to Tysabri (Antegren or Natalizumab)


  • Related topics
    Last post

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service